
Jamie Brannan has been appointed to Zoetis Inc.’s newly created Chief Commercial Officer role. The new commercial organizational structure is expected to accelerate long-term growth strategy in key markets and optimize global commercial operations.
Zoetis Inc. has announced the appointment of Jamie Brannan to a newly created role of Chief Commercial Officer, overseeing all commercial markets across the globe for the animal health company. In this new role, Brannan will lead an evolved commercial organizational structure that will accelerate the company’s long-term growth strategy across key markets, drive greater global commercial collaboration and unlock future growth opportunities, according to Zoetis’ statement.
Jamie Brannan, who is currently Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics, will assume his new role effective immediately. His expanded role includes oversight of commercial operations across the United States and all International markets.
“As we enter the next phase of accelerated growth driven by our innovative and market-leading portfolio, the creation of this role will optimize our commercial operations and best position Zoetis to identify and capitalize on new market opportunities and deliver an exceptional experience for our customers,” says Kristin Peck, Chief Executive Officer of Zoetis. “Jamie is a true enterprise leader who has built high-performing and customer-obsessed leaders and teams. I am confident that Jamie will help Zoetis drive our next phase of growth and continue to deliver excellent performance across markets.”
Jamie Brannan expressed: “Taking on this new role as Chief Commercial Officer is an incredible honor. I’m excited to lead our global commercial teams as we continue to innovate and deliver outstanding value to our customers. Together, we’ll drive Zoetis’ growth strategy, enhance our market presence and ensure we remain at the forefront of animal health solutions worldwide.”
ABOUT JAMIE BRANNAN
As a senior business leader in human and animal health for over a decade, Brannan has consistently demonstrated his ability to build diverse teams with the agility to adjust through fast, evolving business conditions across international markets. Since joining Zoetis in 2016, Jamie Brannan has demonstrated a proven track record of strong commercial leadership, disciplined financial performance and the development of high-performing teams.
He most recently served as Executive Vice President and Group President International Operations, Aquaculture and Global Diagnostics at Zoetis, with responsibility for commercial operations in over 100 international markets, the global aquaculture and diagnostic businesses. Previously, he was President, Zoetis International Operations from June 2021 until November 2022, and Senior Vice President of Zoetis’ Northern Europe Cluster from October 2016 until June 2021.
ADDITIONAL LEADERSHIP CHANGES
At the same time, Zoetis has announced the following additional leadership changes:
• Wafaa Mamilli, currently Executive Vice President, Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health, has informed the company of her decision to leave the organization in early 2025 to pursue an external opportunity. The company regrets her decision but is grateful she will remain at Zoetis until early 2025 to ensure a smooth transition. Since joining Zoetis in 2020, Mamilli has been instrumental in positioning Zoetis as a leader in technology, digital transformation, data analytics and AI within healthcare. She has also overseen two key international markets, China and Brazil, and the company’s precision animal health businesses with a relentless focus on advancing customer success and innovation.
• With Mamilli’s planned departure, Keith Sarbaugh has been promoted to Executive Vice President and Chief Digital & Technology Officer and will join the Zoetis Executive Team, effective immediately. In this role, Sarbaugh will be responsible for the company’s technology, digital, data and analytics strategy and continue to oversee its Customer Experience function. Keith Sarbaugh joined Zoetis in March 2023, and previously served as Vice President and Chief Information Officer. He brings nearly 25 years of tech and digital leadership experience from roles in IT and Commercial teams at Biogen and Eli Lilly.
• Ester Banque, currently Executive Vice President and President, U.S. Operations, will transition out of her role and pursue other opportunities outside of Zoetis. The company is grateful for Banque’s contributions to Zoetis during her tenure, delivering above market performance in the U.S. business. She will serve in an advisory capacity until early 2025 to ensure a smooth transition.
• Jared Shriver has been promoted to President, U.S. Operations, effective immediately, reporting to Jamie Brannan. In his nearly 20-year tenure at Zoetis, Shriver has demonstrated exceptional leadership across various commercial roles within the organization. He has consistently driven performance, exceeding financial targets and fostering a culture of accountability, collaboration, and excellence in sales and marketing. Shriver most recently served as Senior Vice President of U.S. Livestock, Bio Devices, Equine, and Platinum Performance.